ID   MICA3_HUMAN             Reviewed;        2002 AA.
AC   Q7RTP6; B2RXJ5; E9PEF0; O94909; Q5U4P4; Q6ICK4; Q96DF2; Q9P2I3;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 2.
DT   07-APR-2021, entry version 178.
DE   RecName: Full=[F-actin]-monooxygenase MICAL3;
DE            EC=1.14.13.225 {ECO:0000305|PubMed:24440334};
DE   AltName: Full=Molecule interacting with CasL protein 3;
DE            Short=MICAL-3;
GN   Name=MICAL3; Synonyms=KIAA0819, KIAA1364;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1626-2002 (ISOFORM 1), AND NUCLEOTIDE SEQUENCE [LARGE
RP   SCALE MRNA] OF 682-966 (ISOFORM 4).
RC   TISSUE=Lymph, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 166-2002 (ISOFORM 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1014-2002 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI. The
RT   complete sequences of 150 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [6]
RP   IDENTIFICATION (ISOFORM 3 AND PARTIAL ISOFORM 1).
RX   PubMed=12110185; DOI=10.1016/s0092-8674(02)00794-8;
RA   Terman J.R., Mao T., Pasterkamp R.J., Yu H.-H., Kolodkin A.L.;
RT   "MICALs, a family of conserved flavoprotein oxidoreductases, function in
RT   plexin-mediated axonal repulsion.";
RL   Cell 109:887-900(2002).
RN   [7]
RP   INTERACTION WITH RAB1B, SUBCELLULAR LOCATION, ALTERNATIVE SPLICING, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=15694364; DOI=10.1016/j.bbrc.2004.12.182;
RA   Fischer J., Weide T., Barnekow A.;
RT   "The MICAL proteins and rab1: a possible link to the cytoskeleton?";
RL   Biochem. Biophys. Res. Commun. 328:415-423(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1310, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-649; THR-887; SER-1371 AND
RP   SER-1384, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1310 AND THR-1454, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-649; SER-1337 AND THR-1341,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   FUNCTION, INTERACTION WITH ERC1 AND RAB8A, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF 93-GLY--GLY-98.
RX   PubMed=21596566; DOI=10.1016/j.cub.2011.04.030;
RA   Grigoriev I., Yu K.L., Martinez-Sanchez E., Serra-Marques A., Smal I.,
RA   Meijering E., Demmers J., Peranen J., Pasterkamp R.J., van der Sluijs P.,
RA   Hoogenraad C.C., Akhmanova A.;
RT   "Rab6, Rab8, and MICAL3 cooperate in controlling docking and fusion of
RT   exocytotic carriers.";
RL   Curr. Biol. 21:967-974(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1371, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-649; THR-887; SER-1143;
RP   SER-1310; SER-1337; SER-1433; SER-1649; SER-1701 AND SER-1704, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, NUCLEAR LOCALIZATION
RP   SIGNAL, AND MUTAGENESIS OF 680-LYS--LYS-683.
RX   PubMed=24440334; DOI=10.1016/j.cell.2013.12.035;
RA   Lundquist M.R., Storaska A.J., Liu T.C., Larsen S.D., Evans T.,
RA   Neubig R.R., Jaffrey S.R.;
RT   "Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.";
RL   Cell 156:563-576(2014).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1134; SER-1160; SER-1274;
RP   THR-1276; SER-1278; SER-1649 AND THR-1651, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   INTERACTION WITH NINL, AND SUBCELLULAR LOCATION.
RX   PubMed=26485645; DOI=10.1371/journal.pgen.1005575;
RA   Bachmann-Gagescu R., Dona M., Hetterschijt L., Tonnaer E., Peters T.,
RA   de Vrieze E., Mans D.A., van Beersum S.E., Phelps I.G., Arts H.H.,
RA   Keunen J.E., Ueffing M., Roepman R., Boldt K., Doherty D., Moens C.B.,
RA   Neuhauss S.C., Kremer H., van Wijk E.;
RT   "The ciliopathy protein CC2D2A associates with NINL and functions in RAB8-
RT   MICAL3-regulated vesicle trafficking.";
RL   PLoS Genet. 11:E1005575-E1005575(2015).
RN   [18]
RP   FUNCTION, INTERACTION WITH KIF23, AND SUBCELLULAR LOCATION.
RX   PubMed=27528609; DOI=10.1074/jbc.m116.748186;
RA   Liu Q., Liu F., Yu K.L., Tas R., Grigoriev I., Remmelzwaal S.,
RA   Serra-Marques A., Kapitein L.C., Heck A.J., Akhmanova A.;
RT   "MICAL3 flavoprotein monooxygenase forms a complex with centralspindlin and
RT   regulates cytokinesis.";
RL   J. Biol. Chem. 291:20617-20629(2016).
RN   [19]
RP   STRUCTURE BY NMR OF 515-630.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the CH domain from human MICAL-3 protein.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 1841-1990, INTERACTION WITH
RP   RAB1B; RAB8A; RAB10; RAB13 AND RAB15, AND DOMAIN.
RX   PubMed=27552051; DOI=10.7554/elife.18675;
RA   Rai A., Oprisko A., Campos J., Fu Y., Friese T., Itzen A., Goody R.S.,
RA   Gazdag E.M., Muller M.P.;
RT   "bMERB domains are bivalent Rab8 family effectors evolved by gene
RT   duplication.";
RL   Elife 5:E18675-E18675(2016).
CC   -!- FUNCTION: Monooxygenase that promotes depolymerization of F-actin by
CC       mediating oxidation of specific methionine residues on actin to form
CC       methionine-sulfoxide, resulting in actin filament disassembly and
CC       preventing repolymerization. In the absence of actin, it also functions
CC       as a NADPH oxidase producing H(2)O(2). Seems to act as Rab effector
CC       protein and plays a role in vesicle trafficking. Involved in exocytic
CC       vesicles tethering and fusion: the monooxygenase activity is required
CC       for this process and implicates RAB8A associated with exocytotic
CC       vesicles. Required for cytokinesis. Contributes to stabilization and/or
CC       maturation of the intercellular bridge independently of its
CC       monooxygenase activity. Promotes recruitment of Rab8 and ERC1 to the
CC       intercellular bridge, and together these proteins are proposed to
CC       function in timely abscission. {ECO:0000269|PubMed:21596566,
CC       ECO:0000269|PubMed:24440334}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-methionyl-[F-actin] + NADPH + O2 = H2O + L-methionyl-
CC         (R)-S-oxide-[F-actin] + NADP(+); Xref=Rhea:RHEA:51308, Rhea:RHEA-
CC         COMP:12953, Rhea:RHEA-COMP:12956, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16044,
CC         ChEBI:CHEBI:45764, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.14.13.225; Evidence={ECO:0000305|PubMed:24440334};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with RAB1B, RAB8A, RAB10, RAB13 and RAB15 (in their
CC       GTP-bound forms); binding to RAB1B is of low affinity compared to other
CC       Rab proteins; at least in case of RAB8A can bind 2 molecules of RAB8A
CC       simultaneously through a high and a low affinity binding site,
CC       respectively. Interacts with ERC1 and RAB8A; may bridge ERC1 with
CC       RAB8A. Interacts with KIF23 and ERC1; enhances the interaction between
CC       KIF23 and ERC1. Interacts with NINL isoform 2.
CC       {ECO:0000269|PubMed:15694364, ECO:0000269|PubMed:21596566,
CC       ECO:0000269|PubMed:26485645, ECO:0000269|PubMed:27528609,
CC       ECO:0000269|PubMed:27552051}.
CC   -!- INTERACTION:
CC       Q7RTP6-1; Q02241: KIF23; NbExp=8; IntAct=EBI-13945605, EBI-306852;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15694364}.
CC       Cytoplasm, cell cortex {ECO:0000269|PubMed:21596566}. Cytoplasm,
CC       cytoskeleton {ECO:0000269|PubMed:15694364}. Nucleus
CC       {ECO:0000269|PubMed:24440334}. Midbody {ECO:0000269|PubMed:27528609}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:27528609}.
CC       Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000305|PubMed:26485645}. Note=Mainly localizes in the nucleus.
CC       {ECO:0000269|PubMed:24440334}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q7RTP6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7RTP6-2; Sequence=VSP_039487, VSP_039488;
CC       Name=3;
CC         IsoId=Q7RTP6-3; Sequence=VSP_039485, VSP_039487, VSP_039488;
CC       Name=4;
CC         IsoId=Q7RTP6-4; Sequence=VSP_039486, VSP_039489;
CC       Name=5;
CC         IsoId=Q7RTP6-5; Sequence=VSP_042600, VSP_042601, VSP_042602;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:15694364}.
CC   -!- DOMAIN: The bivalent Mical/EHBP Rab binding (bMERB) domain, mediates
CC       binding to predominantly Rab8, Rab10, Rab10, Rab13 and Rab15 (in their
CC       GTP-bound forms). {ECO:0000269|PubMed:27552051}.
CC   -!- SIMILARITY: Belongs to the Mical family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR456364; CAG30250.1; -; mRNA.
DR   EMBL; BX647382; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC016026; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016027; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006562; AAH06562.2; -; mRNA.
DR   EMBL; BC085009; AAH85009.1; -; mRNA.
DR   EMBL; BC157876; AAI57877.1; -; mRNA.
DR   EMBL; BC171887; AAI71887.1; -; mRNA.
DR   EMBL; AB020626; BAA74842.1; -; mRNA.
DR   EMBL; AB037785; BAA92602.1; -; mRNA.
DR   EMBL; BK000464; DAA01343.1; -; mRNA.
DR   EMBL; BK000465; DAA01344.1; -; mRNA.
DR   CCDS; CCDS46659.1; -. [Q7RTP6-1]
DR   CCDS; CCDS46660.1; -. [Q7RTP6-4]
DR   CCDS; CCDS46661.1; -. [Q7RTP6-5]
DR   RefSeq; NP_001116203.1; NM_001122731.2. [Q7RTP6-4]
DR   RefSeq; NP_001129476.1; NM_001136004.3. [Q7RTP6-5]
DR   RefSeq; NP_056056.2; NM_015241.2. [Q7RTP6-1]
DR   RefSeq; XP_005261319.1; XM_005261262.3.
DR   PDB; 2D88; NMR; -; A=518-625.
DR   PDB; 5SZG; X-ray; 2.70 A; A/B=1841-1990.
DR   PDB; 6ICI; X-ray; 2.30 A; A=1-700.
DR   PDBsum; 2D88; -.
DR   PDBsum; 5SZG; -.
DR   PDBsum; 6ICI; -.
DR   BMRB; Q7RTP6; -.
DR   SMR; Q7RTP6; -.
DR   BioGRID; 121609; 43.
DR   IntAct; Q7RTP6; 44.
DR   STRING; 9606.ENSP00000416015; -.
DR   iPTMnet; Q7RTP6; -.
DR   PhosphoSitePlus; Q7RTP6; -.
DR   BioMuta; MICAL3; -.
DR   DMDM; 300669653; -.
DR   EPD; Q7RTP6; -.
DR   jPOST; Q7RTP6; -.
DR   MassIVE; Q7RTP6; -.
DR   MaxQB; Q7RTP6; -.
DR   PaxDb; Q7RTP6; -.
DR   PeptideAtlas; Q7RTP6; -.
DR   PRIDE; Q7RTP6; -.
DR   ProteomicsDB; 68879; -. [Q7RTP6-1]
DR   ProteomicsDB; 68880; -. [Q7RTP6-2]
DR   ProteomicsDB; 68881; -. [Q7RTP6-3]
DR   ProteomicsDB; 68882; -. [Q7RTP6-4]
DR   ProteomicsDB; 68883; -. [Q7RTP6-5]
DR   Antibodypedia; 34804; 27 antibodies.
DR   DNASU; 57553; -.
DR   Ensembl; ENST00000383094; ENSP00000372574; ENSG00000243156. [Q7RTP6-2]
DR   Ensembl; ENST00000400561; ENSP00000383406; ENSG00000243156. [Q7RTP6-4]
DR   Ensembl; ENST00000414725; ENSP00000391827; ENSG00000243156. [Q7RTP6-3]
DR   Ensembl; ENST00000441493; ENSP00000416015; ENSG00000243156. [Q7RTP6-1]
DR   Ensembl; ENST00000585038; ENSP00000462033; ENSG00000243156. [Q7RTP6-5]
DR   GeneID; 57553; -.
DR   KEGG; hsa:57553; -.
DR   UCSC; uc002zng.5; human. [Q7RTP6-1]
DR   CTD; 57553; -.
DR   DisGeNET; 57553; -.
DR   GeneCards; MICAL3; -.
DR   HGNC; HGNC:24694; MICAL3.
DR   HPA; ENSG00000243156; Low tissue specificity.
DR   MIM; 608882; gene.
DR   neXtProt; NX_Q7RTP6; -.
DR   OpenTargets; ENSG00000243156; -.
DR   PharmGKB; PA142671454; -.
DR   VEuPathDB; HostDB:ENSG00000243156.7; -.
DR   eggNOG; KOG1700; Eukaryota.
DR   GeneTree; ENSGT00940000155580; -.
DR   HOGENOM; CLU_000329_1_1_1; -.
DR   InParanoid; Q7RTP6; -.
DR   OMA; ESERIGW; -.
DR   OrthoDB; 430978at2759; -.
DR   PhylomeDB; Q7RTP6; -.
DR   TreeFam; TF324129; -.
DR   PathwayCommons; Q7RTP6; -.
DR   SABIO-RK; Q7RTP6; -.
DR   BioGRID-ORCS; 57553; 4 hits in 991 CRISPR screens.
DR   ChiTaRS; MICAL3; human.
DR   EvolutionaryTrace; Q7RTP6; -.
DR   GeneWiki; MICAL3; -.
DR   GenomeRNAi; 57553; -.
DR   Pharos; Q7RTP6; Tbio.
DR   PRO; PR:Q7RTP6; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q7RTP6; protein.
DR   Bgee; ENSG00000243156; Expressed in cerebellum and 162 other tissues.
DR   ExpressionAtlas; Q7RTP6; baseline and differential.
DR   Genevisible; Q7RTP6; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0090543; C:Flemming body; IDA:HPA.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; ISS:UniProtKB.
DR   GO; GO:0031267; F:small GTPase binding; IEA:InterPro.
DR   GO; GO:0030042; P:actin filament depolymerization; IDA:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007010; P:cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR022735; bMERB_dom.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR002938; FAD-bd.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR029941; MICAL3.
DR   InterPro; IPR001781; Znf_LIM.
DR   PANTHER; PTHR24206:SF66; PTHR24206:SF66; 1.
DR   Pfam; PF00307; CH; 1.
DR   Pfam; PF12130; DUF3585; 1.
DR   Pfam; PF01494; FAD_binding_3; 1.
DR   Pfam; PF00412; LIM; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00132; LIM; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   PROSITE; PS51848; BMERB; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 1.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Alternative splicing; Cell cycle;
KW   Cell division; Cell projection; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Exocytosis; FAD; Flavoprotein; LIM domain; Metal-binding; Monooxygenase;
KW   NADP; Nucleus; Oxidoreductase; Phosphoprotein; Reference proteome; Zinc.
FT   CHAIN           1..2002
FT                   /note="[F-actin]-monooxygenase MICAL3"
FT                   /id="PRO_0000075846"
FT   DOMAIN          518..624
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          762..824
FT                   /note="LIM zinc-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          1841..1990
FT                   /note="bMERB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01195"
FT   NP_BIND         116..118
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDP3"
FT   NP_BIND         123..125
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDP3"
FT   REGION          2..494
FT                   /note="Monooxygenase domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDP3"
FT   COILED          1821..1992
FT                   /evidence="ECO:0000255"
FT   MOTIF           663..684
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:24440334"
FT   COMPBIAS        688..691
FT                   /note="Poly-Glu"
FT   COMPBIAS        889..1138
FT                   /note="Glu-rich"
FT   COMPBIAS        1141..1505
FT                   /note="Pro-rich"
FT   METAL           764
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           767
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           785
FT                   /note="Zinc 1; via pros nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           788
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           791
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           794
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           814
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   METAL           817
FT                   /note="Zinc 2; via pros nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TDZ2"
FT   BINDING         97
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDP3"
FT   BINDING         183
FT                   /note="FAD; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDP3"
FT   BINDING         298
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDP3"
FT   BINDING         398
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDP3"
FT   MOD_RES         649
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         685
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CJ19"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CJ19"
FT   MOD_RES         887
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         977
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CJ19"
FT   MOD_RES         1134
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1192
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CJ19"
FT   MOD_RES         1274
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1276
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1278
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         1337
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1341
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         1371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         1384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         1433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1454
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         1649
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         1651
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1701
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1704
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1912
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CJ19"
FT   VAR_SEQ         746
FT                   /note="R -> RQLTQERGASQPSCCLPGQVRPAPTPRWK (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10718198"
FT                   /id="VSP_039485"
FT   VAR_SEQ         747
FT                   /note="Q -> QQREKECSRTCPKKVITLSPPPTPPPCRAHGGQQTYRDLDADNRGKQ
FT                   SPHHERPEPEPPRRFFVDQWELSLSLRSSARPASPSSDSLRQKYIKMYTGGVSSLAEQI
FT                   ANQLQRKEQPKALLDKKEL (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042600"
FT   VAR_SEQ         871..949
FT                   /note="GVNGLEEPSIAKRLRGTPERIELENYRLSLRQAEALQEVPEETQAEHNLSSV
FT                   LDTGAEEDVASSSSESEMEEEGEEEEE -> LTSLFGWVARHSLGLCDKAKGMSQHLQS
FT                   NISSFGQQVAQNPLDSFFMCQLLAFGVPFLYGLSEVLVQIRGEFHWQAVAQ (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042601"
FT   VAR_SEQ         934..966
FT                   /note="SSSESEMEEEGEEEEEEPRLPPSDLGGVPWKEA -> RDWVSPWLPRMVSNS
FT                   WAQMIHPPQPPTVLGSQM (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_039486"
FT   VAR_SEQ         934..948
FT                   /note="SSSESEMEEEGEEEE -> RSARRAAGRPPATRP (in isoform 2 and
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10718198,
FT                   ECO:0000303|PubMed:15461802"
FT                   /id="VSP_039487"
FT   VAR_SEQ         949..2002
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10718198,
FT                   ECO:0000303|PubMed:15461802"
FT                   /id="VSP_039488"
FT   VAR_SEQ         950..2002
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042602"
FT   VAR_SEQ         967..2002
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_039489"
FT   VARIANT         11
FT                   /note="P -> A (in dbSNP:rs11913706)"
FT                   /id="VAR_059451"
FT   VARIANT         745
FT                   /note="R -> Q (in dbSNP:rs2289719)"
FT                   /id="VAR_059452"
FT   VARIANT         750
FT                   /note="M -> L (in dbSNP:rs5992128)"
FT                   /id="VAR_018263"
FT   MUTAGEN         93..98
FT                   /note="GAGPCG->WAWPCW: Abolishes Monooxygenase activity and
FT                   impairs ability to control docking and fusion of exocytic
FT                   carriers."
FT                   /evidence="ECO:0000269|PubMed:21596566"
FT   MUTAGEN         680..683
FT                   /note="KRRK->AAAA: In MICAL-3NLSMut; abolishes nuclear
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:24440334"
FT   CONFLICT        414
FT                   /note="G -> D (in Ref. 2; BX647382)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1245
FT                   /note="Q -> R (in Ref. 5; BAA74842)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1717
FT                   /note="E -> V (in Ref. 4; AAH06562)"
FT                   /evidence="ECO:0000305"
FT   HELIX           11..20
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           25..38
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   TURN            46..48
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           49..56
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           60..73
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           76..81
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   TURN            82..86
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          88..92
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           96..107
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          111..115
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          126..128
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           131..139
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           142..145
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   TURN            147..150
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          156..158
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           159..172
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          176..180
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          182..187
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          201..206
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           210..213
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          217..221
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           224..226
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          234..238
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          243..250
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           255..259
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           272..282
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          286..303
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           305..310
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           321..324
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           327..329
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           332..346
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   TURN            347..349
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          362..364
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          366..370
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          372..378
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          380..386
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          389..395
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           397..399
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           405..407
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           410..429
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           434..445
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           446..450
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   TURN            453..455
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           460..462
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           467..469
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           481..487
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          519..521
FT                   /evidence="ECO:0007744|PDB:2D88"
FT   HELIX           522..532
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   STRAND          535..537
FT                   /evidence="ECO:0007744|PDB:2D88"
FT   STRAND          541..544
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           545..547
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           551..560
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   TURN            562..564
FT                   /evidence="ECO:0007744|PDB:2D88"
FT   TURN            567..569
FT                   /evidence="ECO:0007744|PDB:2D88"
FT   HELIX           575..590
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           598..602
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           609..623
FT                   /evidence="ECO:0007744|PDB:6ICI"
FT   HELIX           1842..1877
FT                   /evidence="ECO:0007744|PDB:5SZG"
FT   HELIX           1887..1889
FT                   /evidence="ECO:0007744|PDB:5SZG"
FT   HELIX           1892..1938
FT                   /evidence="ECO:0007744|PDB:5SZG"
FT   HELIX           1942..1944
FT                   /evidence="ECO:0007744|PDB:5SZG"
FT   HELIX           1947..1980
FT                   /evidence="ECO:0007744|PDB:5SZG"
FT   CONFLICT        Q7RTP6-4:957
FT                   /note="Q -> R (in Ref. 2; BX647382)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2002 AA;  224295 MW;  F85C97FD4D647B80 CRC64;
     MEERKHETMN PAHVLFDRFV QATTCKGTLK AFQELCDHLE LKPKDYRSFY HKLKSKLNYW
     KAKALWAKLD KRGSHKDYKK GKACTNTKCL IIGAGPCGLR TAIDLSLLGA KVVVIEKRDA
     FSRNNVLHLW PFTIHDLRGL GAKKFYGKFC AGAIDHISIR QLQLILLKVA LILGIEIHVN
     VEFQGLIQPP EDQENERIGW RALVHPKTHP VSEYEFEVII GGDGRRNTLE GFRRKEFRGK
     LAIAITANFI NRNTTAEAKV EEISGVAFIF NQKFFQELRE ATGIDLENIV YYKDDTHYFV
     MTAKKQSLLD KGVILHDYAD TELLLSRENV DQEALLSYAR EAADFSTQQQ LPSLDFAINH
     YGQPDVAMFD FTCMYASENA ALVREQNGHQ LLVALVGDSL LEPFWPMGTG IARGFLAAMD
     SAWMVRSWSL GTSPLEVLAE RESIYRLLPQ TTPENVSKNF SQYSIDPVTR YPNINVNFLR
     PSQVRHLYDT GETKDIHLEM ESLVNSRTTP KLTRNESVAR SSKLLGWCQR QTDGYAGVNV
     TDLTMSWKSG LALCAIIHRY RPDLIDFDSL DEQNVEKNNQ LAFDIAEKEL GISPIMTGKE
     MASVGEPDKL SMVMYLTQFY EMFKDSLPSS DTLDLNAEEK AVLIASTRSP ISFLSKLGQT
     ISRKRSPKDK KEKDLDGAGK RRKTSQSEEE EAPRGHRGER PTLVSTLTDR RMDVAVGNQN
     KVKYMATQLL AKFEENAPAQ SIGIRRQGSM KKEFPQNLGG SDTCYFCQKR VYVMERLSAE
     GKFFHRSCFK CEYCATTLRL SAYAYDIEDG KFYCKPHYCY RLSGYAQRKR PAVAPLSGKE
     AKGPLQDGAT TDANGRANAV ASSTERTPGS GVNGLEEPSI AKRLRGTPER IELENYRLSL
     RQAEALQEVP EETQAEHNLS SVLDTGAEED VASSSSESEM EEEGEEEEEE PRLPPSDLGG
     VPWKEAVRIH ALLKGKSEEE LEASKSFGPG NEEEEEEEEE YEEEEEEDYD EEEEESSEAG
     NQRLQQVMHA ADPLEIQADV HWTHIREREE EERMAPASES SASGAPLDEN DLEEDVDSEP
     AEIEGEAAED GDPGDTGAEL DDDQHWSDSP SDADRELRLP CPAEGEAELE LRVSEDEEKL
     PASPKHQERG PSQATSPIRS PQESALLFIP VHSPSTEGPQ LPPVPAATQE KSPEERLFPE
     PLLPKEKPKA DAPSDLKAVH SPIRSQPVTL PEARTPVSPG SPQPQPPVAA STPPPSPLPI
     CSQPQPSTEA TVPSPTQSPI RFQPAPAKTS TPLAPLPVQS QSDTKDRLGS PLAVDEALRR
     SDLVEEFWMK SAEIRRSLGL TPVDRSKGPE PSFPTPAFRP VSLKSYSVEK SPQDEGLHLL
     KPLSIPKRLG LPKPEGEPLS LPTPRSPSDR ELRSAQEERR ELSSSSGLGL HGSSSNMKTL
     GSQSFNTSDS AMLTPPSSPP PPPPPGEEPA TLRRKLREAE PNASVVPPPL PATWMRPPRE
     PAQPPREEVR KSFVESVEEI PFADDVEDTY DDKTEDSSLQ EKFFTPPSCW PRPEKPRHPP
     LAKENGRLPA LEGTLQPQKR GLPLVSAEAK ELAEERMRAR EKSVKSQALR DAMARQLSRM
     QQMELASGAP RPRKASSAPS QGKERRPDSP TRPTLRGSEE PTLKHEATSE EVLSPPSDSG
     GPDGSFTSSE GSSGKSKKRS SLFSPRRNKK EKKSKGEGRP PEKPSSNLLE EAAAKPKSLW
     KSVFSGYKKD KKKKADDKSC PSTPSSGATV DSGKHRVLPV VRAELQLRRQ LSFSEDSDLS
     SDDVLEKSSQ KSRREPRTYT EEELNAKLTR RVQKAARRQA KQEELKRLHR AQIIQRQLQQ
     VEERQRRLEE RGVAVEKALR GEAGMGKKDD PKLMQEWFKL VQEKNAMVRY ESELMIFARE
     LELEDRQSRL QQELRERMAV EDHLKTEEEL SEEKQILNEM LEVVEQRDSL VALLEEQRLR
     EREEDKDLEA AMLSKGFSLN WS
//
